VLDLR and hyperlipidemia: Western blot analysis showed that puerarin remarkably inhibited hyperlipidaemia by regulating the expression of cholesterol 7a-hydroxylase (CYP7A1), HMGR and low-density lipoprotein receptors in the liver of lead-treated rats [22].